Loading market dashboard
TriSalus Life Sciences, Inc.
TLSIHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
TriSalus Life Sciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $180.79M | $172.51M - $191.10M | -$166.21M | $1.07 | 1 |
| Dec 2029 | $138.58M | $132.24M - $146.49M | -$127.41M | $0.543 | 2 |
| Dec 2028 | $109.01M | $109.01M - $109.01M | -$100.22M | $0.26 | 3 |
| Dec 2027 | $78.41M | $74.82M - $82.88M | -$72.09M | -$0.164 | 3 |
| Dec 2026 | $53.67M | $51.21M - $56.73M | -$49.34M | -$0.322 | 3 |
| Dec 2025 | $44.76M | $42.71M - $47.32M | -$41.15M | -$1.763 | 1 |
| Dec 2024 | $29.26M | $29.22M - $29.29M | -$26.90M | -$1.263 | 3 |
| Dec 2023 | $24.74M | $23.60M - $26.15M | -$22.74M | -$2.725 | 2 |